Opportunity Information: Apply for RFA DA 26 055

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed) is a National Institutes of Health (NIH) grant opportunity (Funding Opportunity Number RFA-DA-26-055) designed to push substance use research forward by making stronger, more creative use of data that already exist. Instead of funding new clinical trials, the program centers on innovative secondary analyses of extant datasets, including social science, behavioral, administrative, and neuroimaging data. The overall intent is to help researchers extract more value from public-use or otherwise available community-based and clinical datasets to answer high-impact questions about substance use and related health outcomes.

The scientific scope is broad but clearly focused on understanding drug-using behaviors and their consequences across the lifespan and across populations. "Drug using behaviors" is defined here in an inclusive way that covers alcohol, tobacco, prescription drugs, and other drugs, along with related substance use disorders. Applications are encouraged to address etiologic and epidemiologic questions, meaning work that clarifies why substance use starts, how it changes over time, and what factors shape its distribution and burden in communities. A key theme is trajectory research: identifying patterns of initiation, escalation, remission, relapse, and polysubstance use, and linking those patterns to downstream outcomes such as morbidity and mortality.

The opportunity also emphasizes prevention and service-related research, including prevention of drug use and HIV, as well as health service utilization. In practice, this means proposals can focus not only on individual-level risk and protective factors, but also on systems-level questions such as access to care, treatment engagement, retention, quality of services, and the real-world delivery of prevention and treatment interventions. The NOFO highlights interest in research on risk and resilience in the development of psychopathology, encouraging applicants to study how substance use interacts with mental health and broader behavioral health outcomes. The program is also positioned to support analyses that can guide the development, testing, implementation, and delivery of high-quality, effective, and efficient prevention and treatment services, particularly when existing datasets can be leveraged to produce actionable insights.

As an R01 mechanism, this is meant for substantial, hypothesis-driven projects with rigorous analytic plans, strong measurement strategies, and clear potential to advance knowledge. Because the NOFO specifies "Clinical Trial Not Allowed," the work should not involve conducting a new clinical trial; it should rely on existing data sources, which may include large observational cohorts, administrative claims, electronic health records (when appropriately accessed and governed), longitudinal surveys, registries, clinical datasets, or previously collected neuroimaging datasets. Competitive applications will typically show that the dataset is well-suited to the research questions, that the analytic approach is innovative and appropriate (for example, advanced causal inference, longitudinal modeling, machine learning used responsibly, or harmonization across datasets), and that the results will meaningfully inform substance use science, prevention, HIV-related outcomes, or service delivery.

Eligibility is intentionally expansive. Eligible applicants include a wide range of U.S. government entities (state, county, city/township, and special district governments), independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education), for-profit organizations (other than small businesses), small businesses, public housing authorities/Indian housing authorities, and Native American tribal governments (federally recognized) as well as tribal organizations (other than federally recognized tribal governments). The NOFO also explicitly calls out additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-domestic (non-U.S.) entities (foreign organizations). This broad eligibility signals a desire for diverse applicants and settings, and for research that can speak to varied communities and health systems.

Administratively, this is a discretionary grant program under NIH, with activity areas spanning education and health, and associated CFDA numbers 93.273 and 93.279. The opportunity was created on 2024-12-05, and the listed original closing date is 2027-12-03. The award ceiling and expected number of awards are not specified in the provided source data, which often means applicants should consult the full NOFO text and NIH standard policies for budget expectations and competitiveness factors.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273, 93.279.
  • This funding opportunity was created on 2024-12-05.
  • Applicants must submit their applications by 2027-12-03.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA DA 26 055

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)

Previous opportunity: Nuclear Data Interagency Working Group (NDIAWG) Research Program

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 26 055

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 26 055) also looked into and applied for these:

Funding Opportunity
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional) Apply for PAR 25 100

Funding Number: PAR 25 100
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) Apply for PAR 24 330

Funding Number: PAR 24 330
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed) Apply for RFA HG 25 007

Funding Number: RFA HG 25 007
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $400,000
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) Apply for PAR 25 321

Funding Number: PAR 25 321
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) Apply for PAR 25 346

Funding Number: PAR 25 346
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required) Apply for RFA AA 24 012

Funding Number: RFA AA 24 012
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional) Apply for PAR 25 317

Funding Number: PAR 25 317
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) Apply for PAR 25 325

Funding Number: PAR 25 325
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional) Apply for PAS 25 236

Funding Number: PAS 25 236
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $100,000
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Apply for RFA CA 25 003

Funding Number: RFA CA 25 003
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Apply for RFA CA 25 001

Funding Number: RFA CA 25 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 25 004

Funding Number: RFA CA 25 004
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 25 002

Funding Number: RFA CA 25 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed) Apply for PAR 25 336

Funding Number: PAR 25 336
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional) Apply for RFA CA 25 019

Funding Number: RFA CA 25 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) Apply for PAR 25 101

Funding Number: PAR 25 101
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Ex Vivo Models for Studies at the Intersection of HIV and Addictive Substance Use (R01 Clinical Trial Not Allowed) Apply for RFA DA 25 074

Funding Number: RFA DA 25 074
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) Apply for RFA CA 25 005

Funding Number: RFA CA 25 005
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) Apply for RFA CA 25 007

Funding Number: RFA CA 25 007
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) Apply for RFA CA 25 006

Funding Number: RFA CA 25 006
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 26 055", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: